Starlix is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Nateglinide.
| Product ID | 0078-0351_30f5d4e8-235e-437d-8586-76bae702e8b2 |
| NDC | 0078-0351 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Starlix |
| Generic Name | Nateglinide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2000-12-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021204 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | NATEGLINIDE |
| Active Ingredient Strength | 60 mg/1 |
| Pharm Classes | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2000-12-04 |
| Marketing End Date | 2021-09-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021204 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2000-12-04 |
| Marketing End Date | 2021-09-30 |
| Ingredient | Strength |
|---|---|
| NATEGLINIDE | 60 mg/1 |
| SPL SET ID: | 5cbda9bc-3c0d-4d75-a37a-994844680c8c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0351 | Starlix | nateglinide |
| 0078-0352 | Starlix | nateglinide |
| 0591-3354 | Nateglinide | Nateglinide |
| 0591-3355 | Nateglinide | Nateglinide |
| 0615-7585 | Nateglinide | Nateglinide |
| 0615-7586 | Nateglinide | Nateglinide |
| 16571-758 | NATEGLINIDE | NATEGLINIDE |
| 16571-759 | NATEGLINIDE | NATEGLINIDE |
| 42291-636 | Nateglinide | Nateglinide |
| 42291-637 | Nateglinide | Nateglinide |
| 49884-984 | Nateglinide | Nateglinide |
| 49884-985 | Nateglinide | Nateglinide |
| 51407-656 | Nateglinide | nateglinide |
| 51407-657 | Nateglinide | nateglinide |
| 52536-063 | Nateglinide | Nateglinide |
| 52536-067 | Nateglinide | Nateglinide |
| 55111-328 | Nateglinide | Nateglinide |
| 55111-329 | Nateglinide | Nateglinide |
| 60429-434 | Nateglinide | Nateglinide |
| 60429-435 | Nateglinide | Nateglinide |
| 60687-673 | Nateglinide | nateglinide |
| 60687-684 | Nateglinide | nateglinide |
| 64380-167 | Nateglinide | nateglinide |
| 64380-168 | Nateglinide | nateglinide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() STARLIX 74614502 not registered Dead/Abandoned |
SANDOZ AG (SANDOZ LTD., SANDOZ S.A.) 1994-12-22 |
![]() STARLIX 74476003 2152672 Live/Registered |
Novartis AG 1994-01-03 |